Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solveig Hofvind

Showing results (41-50 of 228) with videos related to

Pageof 23
Sort By:
Breast Cancer Research and Treatment|May 4, 2011
Second events following ductal carcinoma in situ of the breast: a register-based cohort studyRagnhild Sørum Falk, Solveig Hofvind, Per Skaane, et al.
International Journal of Cancer|July 7, 2011
Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?Solveig Hofvind, Solveig Sakshaug, Giske Ursin, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|February 17, 2018
Mammographic screening attendance among immigrant and minority women: a systematic review and meta-analysisSameer Bhargava, Kåre Moen, Samera Azeem Qureshi, et al.
International Journal of Cancer|January 29, 2013
Overdiagnosis among women attending a population-based mammography screening programRagnhild Sørum Falk, Solveig Hofvind, Per Skaane, et al.
International Journal of Cancer|May 8, 2013
Response to comments by Kalager et al. and Zahl et alRagnhild Sørum Falk, Solveig Hofvind, Per Skaane, et al.
Lancet (London, England)|May 15, 2013
The benefits and harms of breast cancer screeningEugenio Paci, Mireille Broeders, Solveig Hofvind, et al.
Journal of Medical Screening|May 3, 2022
Participation and cancer detection after reminders versus ordinary invitations in BreastScreen NorwayJonas E Thy, Einar Vigeland, Marthe Larsen, et al.
Cancer|December 21, 2021
Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen NorwayKaitlyn M Tsuruda, Marthe Larsen, Marta Román, et al.
European Radiology|January 24, 2021
Can artificial intelligence reduce the interval cancer rate in mammography screening?Kristina Lång, Solveig Hofvind, Alejandro Rodríguez-Ruiz, et al.
Journal of Medical Screening|January 22, 2014
Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of cautionStephen W Duffy, Dimitrios Michalopoulos, Sofie Sebuødegård, et al.
Pageof 23

Showing results (41-50 of 228) with videos related to

Sort By:
Pageof 23
Breast Cancer Research and Treatment|May 4, 2011
Second events following ductal carcinoma in situ of the breast: a register-based cohort studyRagnhild Sørum Falk, Solveig Hofvind, Per Skaane, et al.
International Journal of Cancer|July 7, 2011
Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?Solveig Hofvind, Solveig Sakshaug, Giske Ursin, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|February 17, 2018
Mammographic screening attendance among immigrant and minority women: a systematic review and meta-analysisSameer Bhargava, Kåre Moen, Samera Azeem Qureshi, et al.
International Journal of Cancer|January 29, 2013
Overdiagnosis among women attending a population-based mammography screening programRagnhild Sørum Falk, Solveig Hofvind, Per Skaane, et al.
International Journal of Cancer|May 8, 2013
Response to comments by Kalager et al. and Zahl et alRagnhild Sørum Falk, Solveig Hofvind, Per Skaane, et al.
Lancet (London, England)|May 15, 2013
The benefits and harms of breast cancer screeningEugenio Paci, Mireille Broeders, Solveig Hofvind, et al.
Journal of Medical Screening|May 3, 2022
Participation and cancer detection after reminders versus ordinary invitations in BreastScreen NorwayJonas E Thy, Einar Vigeland, Marthe Larsen, et al.
Cancer|December 21, 2021
Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen NorwayKaitlyn M Tsuruda, Marthe Larsen, Marta Román, et al.
European Radiology|January 24, 2021
Can artificial intelligence reduce the interval cancer rate in mammography screening?Kristina Lång, Solveig Hofvind, Alejandro Rodríguez-Ruiz, et al.
Journal of Medical Screening|January 22, 2014
Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of cautionStephen W Duffy, Dimitrios Michalopoulos, Sofie Sebuødegård, et al.
Pageof 23